We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A plastic model of the human brain, bisected.

Scientists Pinpoint Brain Region Crucial for Attention Control

A bag of medication hanging on a drip stand.

Targeted Liver Cancer Treatment May Help Cut Side Effects

Green and teal capsules spill from a prescription bottle.

Dementia Drug Doesn’t Increase Risk of Death or Fatal Heart Condition, Study Finds

Epilepsy Drug Prevents Brain Tumors in Mice With Genetic Condition

Antibiotics Have Limited Impact on Lower Tract Respiratory Infections

Metformin Activates Immune Defenses Against Breast Cancer

News

Plexera Bioscience Announces Agreement with Leading Therapeutic Antibody Company

Plexera has signed an Early Access Agreement with an undisclosed therapeutic antibody company as its first participant in its Early Access Program.

BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology

Dalton Medicinal Chemistry will utilize their proprietary insights to design and synthesize several classes of compounds against selected RiboSwitch targets.

NextGen Sciences Appoints new CEO and Expands Service Offering

The Company appoints Dr Mike Pisano as CEO, and announces the expansion of its portfolio of services to include clinical protein biomarker monitoring.

Aureus Pharma Announces Renewal and Expansion of Licensing

Agreement with Bristol-Myers Squibb for Aureus’ AurSCOPE Knowledge databases.

Applied Biosystems and BioTrove to Collaborate on Integrated Platform for High Throughput Genotyping

Platform will simplify workflows and expand use of TaqMan® assays for a wide range of genotyping applications.

DIREVO and Pfizer Collaborate on Therapeutic Proteases

Direvo will apply its protein-engineering capabilities to create proteases with engineered specificity for different targets as potential treatments for various diseases.

Cambria Receives $5 Million Grants for Neurodegenerative Disease Drug Discovery and Preclinical Development Program

The grant funding will support the company’s drug discovery programs amyotrophic lateral sclerosis, muscular dystrophy and Parkinson’s disease.

Beactica Announces Drug Discovery Collaboration with Arrow Therapeutics

Beactica will direct its characterization technology at selected Arrow compounds against a confidential target.

Advion BioServices Announces Expansion

The Company is expanding its capacity with the recent acquisition of two Applied Biosystems/MDS Sciex API 5000 mass spectrometers and Waters Acquity UPLC capability.

PsychoGenics Announces Drug Discovery Agreement with Cephalon

Both companies will work together to identify new treatments for neuropsychiatric disorders.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter